The evidence also indicates a reduction of oral mucositis in adults receiving high-dose melphalan-based cancer treatment prior to haematopoietic stem cell transplantation, although there is uncertainty regarding the size of the reduction in this instance. No evidence was found for use of this preventive measure in children.
The findings indicate a decrease in oral mucositis in adults receiving high-dose melphalan-based cancer treatment before hematopoietic stem cell transplantation, although the precise size of this reduction is unclear. No evidence was found for using this preventive measure in children.